Study of the telomerase hTERT fraction, PCNA and CD34 expression on pituitary adenomas. Association with clinical and demographic characteristics

Journal of Neuro-Oncology

Volumn 84, Issue 2, 2007, Pages 159-166

  Ortiz Plata, Alma ^a   Tena Suck, Martha Lilia ^a   López Gómez, Mario ^a   Heras, Alfonso ^b   Sánchez García, Aurora ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b BIO SB   (United States)

Author keywords

CD34; Immunohistochemistry; PCNA; Pituitary adenomas; Telomerase

Indexed keywords

CD34 ANTIGEN; CYCLINE; FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; PROLACTIN; TELOMERASE REVERSE TRANSCRIPTASE; THYROTROPIN;

ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; FEMALE; FISHER EXACT TEST; FOLLITROPIN BLOOD LEVEL; GENE EXPRESSION; GROWTH HORMONE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; LUTEINIZING HORMONE BLOOD LEVEL; MALE; ONSET AGE; PROGNOSIS; PROLACTIN BLOOD LEVEL; RANK SUM TEST; SMOKING; THYROTROPIN BLOOD LEVEL;

ADENOMA; ADULT; AGE OF ONSET; ANTIGENS, CD34; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 34547622684     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9365-8     Document Type: Article

References (51)

1. Hardy J (1969) Transphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg 16:185-217
2. Kovacs K, Horvath E, Vidal S (2001) Classification of pituitary adenomas. J Neurooncol 54:121-127
3. Asa SL (1994) Disease of the pituitary. Neuropathology 5:71-95
4. Ahmed A, Tollefsbol T (2003) Telomeres, telomerase, and telomerase inhibition: Clinical implications for cancer. J Am Geriatr Soc 51:116-122
5. Nakatani K, Yoshimi N, Mori H, Yoshimura S, Sakai H, Shinoda J, Sakai N (1997) The significant role of telomerase activity in human brain tumors. Cancer 80:471-476
6. Hiraga S, Ohnishi T, Izumoto S, Miyahara E, Kanemura Y, Matsumura H, Arita N (1998) Telomerase activity and alterations in telomere length in human brain tumors. Cancer Res 58:2117-2125
7. Toh WH, Kyo S, Sabapathy K (2005) Relief of p53-mediated telomerase suppression by p73. J Biol Chem 280:17329-17338
8. DeMasters BK, Markham N, Lillehei KO, Shroyer KR (1997) Differential telomerase expression in human primary intracranial tumor. Am J Clin Pathol 107:548-554
9. Hiyama E, Hiyama K, Nishiyama M, Reynolds CP, Shay JW, Yokoyama T (2003) Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity. J Pediatr Surg 38:1730-1734
10. Didiano D, Shalaby T, Lang D, Grotzer MA (2004) Telomere maintenance in childhood primitive neuroectodermal brain tumors. Neuro-oncology 6:1-8
11. Bratthauer GL, Adams LR (1994) Immunohistochemistry: Antigen detection in tissue. In: Mikel UV (ed) Advanced laboratory methods in histology and pathology. Armed Forces Institute of Pathology, American Registry of Pathology, Washington
12. Arrieta O, Guevara P, Tamariz J, Rembao D, Rivera E, Sotelo J (2002) Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma. Int J Exp Pathol 83:99-104
13. Li TJ, Browne RM, Matthews JB (1994) Quantification of PCNA+ cells within odontogenic jaw cyst epithelium. J Oral Pathol Med 23:184-189
14. Xia Y-P, Zhao Y, Marcus J, Jimenez PA, Ruben SM, Moore PA, Khan F, Mustoe TA (1999) Effects of keratinocyte growth factor-2 (KGF-2) on wound healing in an ischaemia-impaired rabbit ear model and on scar formation. J Pathol 188:431-438
15. Niveiro M, Aranda FI, Peiró G, Alenda C, Pico A (2005) Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. Hum Pathol 36:1090-1095
16. Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460
17. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11:1921-1929
18. Kotoula V, Barbanis S, Nokolakaki E, Koufoyannis D, Papadimitriou CS, Karkavelas G (2004) Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas. Acta Neuropathol (Berl) 107:443-451
19. Dong CK, Masutomi K, Hahn WC (2005) Telomerase: Regulation, function and transformation. Crit Rev Oncol Hematol 54:85-93
20. Sebastian S, Grammatica L, Paradiso A (2005) Telomeres, telomerase and oral cancer. Int J Oncol 27:1583-1596
21. Langford LA, Piatyszek MA, Xu R, Schold SC Jr, Shay JW (1995) Telomerase activity in human brain tumours. Lancet 346:1267-1268
22. Yoshino A, Katayama Y, Fukushima T, Watanabe T, Komine C, Yokoyama T, Kusama K, Moro I (2003) Telomerase activity in pituitary adenomas: significance of telomerase expression in predicting pituitary adenoma recurrence. J Neurooncol 63:155-162
23. Tanaka Y, Hongo K, Tada T, Sakai K, Kakizawa Y, Kobayashi S (2003) Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. J Neurosurg 98:359-365
24. Harada K, Arita K, Kurisu K, Tahara H (2000) Telomerase activity and the expression of telomerase components in pituitary adenoma with malignant transformation. Surg Neurol 53:267-274
25. Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloyd RV (2001) Microvessel density in pituitary adenomas and carcinoma. Virchows Arch 438:595-602
26. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA (2000) Angiogenesis in pituitary adenomas-relationship to endocrine function, treatment and outcome. J Endocrinol 165:475-481
27. Itoh J, Serizawa A, Kawai K, Ishii Y, Teramoto A, Osamura RY (2003) Vascular networks and endothelial cells in the rat experimental pituitary glands and in the human pituitary adenomas. Microsc Res Tech 60:231-235
28. Turner HE, Harris AL, Melmed S, Wass JA (2003) Angiogenesis in endocrine tumors. Endocr Rev 24:600-632
29. Yamada S, Takada K (2003) Angiogenesis in pituitary adenomas. Microsc Res Tech 60:236-243
30. Tella JOI, Herculano MA, Delcelo R (2000) Pituitary adenomas: relationship between invasiveness and proliferative cell nuclear index. Arq Neuropsiquiatr 58:1055-1063
31. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H (1987) Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326:515-517
32. Blevins LS Jr, Verity DK, Allen G (1998) Aggressive pituitary tumors. Oncology 12:1307-1312
33. Hsu DW, Hakim F, Biller BM, de la Monte S, Zervas NT, Klibanski A, Hedley-Whyte ET (1993) Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 78:753-761
34. Schreiber S, Saeger W, Ludecke DK (1999) Proliferation markers in different types of clinically non-secreting pituitary adenomas. Pituitary 1:213-220
35. Klencki M, Kurnatowska I, Slowinska-Klencka D, Lewinski A, Pawlikowski M (2001) Correlation between PCNA expression and AgNOR dots in pituitary adenomas. Endocr Pathol 12:163-169
36. Nose-Alberti V, Mesquita MI, Martin LC, Kayath MJ (1998) Adrenocorticotropin-producing pituitary carcinoma with expression of c-erbB-2 and high PCNA index: A comparative study with pituitary adenomas and normal pituitary tissues. Endocr Pathol 9:53-62
37. Hashimoto K, Nagano I, Asaba K, Inoue M, Nishioka T, Takao T, Nakajo T, Mori T, Kurisaka M, Otsuka F (2000) Significant gene expression of insulin-like growth factor II and proliferating cell nuclear antigen in a rapidly growing recurrent pituitary acth-secreting adenoma. Horm Res 54:198-202
38. Bertholon-Gregoire M, Trouillas J, Guigard MP, Loras B, Tourniaire J (1999) Mono and plurihormonal thyrotropic pituitary adenoma pathological, hormonal and clinical studies in 12 patients. Eur J Endocrinol 140:519-527
39. Wolfsberger S, Wunderer J, Zachenhofer I, Czech T, Bocher-Schwarz HG, Hainfellner J, Knosp E (2004) Expression of cell proliferation markers in pituitary adenomas-correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha. Acta Neurochir (Wien) 146:831-839
40. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws ER Jr (1996) Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the MIB-1 antibody. Neurosurgery 38:99-106
41. Yonezawa K, Tamaki N, Kokunai T (1997) Clinical features and growth fractions of pituitary adenomas. Surg Neurol 48:494-500
42. Autrup H (1993) Transplacental transfer of genotoxins and transplacental carcinogénesis. Environ Health Perspect 101:33-38
43. Birrenbach T, Bocker U (2004) Inflammatory bowel disease and smoking: A review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 10:848-859
44. Lynch HT, Brand RE, Lynch JF, Fusaro RM, Kern SE (2002) Hereditary factors in pancreatic cancer. J Hepatobiliary Pancreat Surg 9:12-31
45. Razani-Boroujerdi S, Sopori ML (2006) Early manifestations of NNK-induced lung cancer: Role of lung immunity in tumor susceptibility. Am J Respir Cell Mol Biol (Epub ahead of print)
46. Sasco AJ, Vainio H (1999) From in utero and childhood exposure to parental smoking to childhood cancer: A possible link and the need for action. Hum Exp Toxicol 18:192-201
47. Phillips LE, Longstreth WT Jr, Koepsell T, Custer BS, Kukull WA, van Belle G (2005) Active and passive cigarette smoking and risk of intracranial meningioma. Neuroepidemiology 24:117-122
48. Hurley SF, McNeil JJ, Donnan GA, Forbes A, Salzberg M, Giles GG (1996) Tobacco smoking and alcohol consumption as risk factors for glioma: A case-control study in Melbourne, Australia. J Epidemiol Community Health 50:442-446
49. Fuxe K, Andersson K, Eneroth P, Harfstrand A, Agnati LF (1989) Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications. Psychoneuroendocrinology 14:19-41
50. Andersson K (1985) Mecamylamine pretreatment counteracts cigarette smoke induced changes in hypothalamic catecholamine neuron systems and in anterior pituitary function. Acta Physiol Scand 125:445-452
51. Kapoor D, Jones TH (2005) Smoking and hormones in health and endocrine disorders. Eur J Endocrinol 152:491-499